share_log

莱美药业(300006.SZ):子公司收到2021年产业扶持专项资金5519万元

Laimei Pharmaceutical (300006.SZ): The subsidiary received 55.19 million yuan in special funding for industry support in 2021

Gelonghui Finance ·  Dec 29, 2022 17:00

Gelonghui December 29th 丨Laimei Pharmaceutical (300006.SZ) announced that the company's holding subsidiary Tibet Laimei Deji Pharmaceutical Co., Ltd. recently received 2021 industrial support special funds issued by the Management Committee of the Tibet Lhasa Economic and Technological Development Zone in accordance with the relevant provisions of the “Implementation Opinions of the Lhasa Economic and Technological Development Zone on Further Promoting High-Quality Industrial Development”, totaling RMB 55.19 million, accounting for 54.90% of the absolute value of the company's most recent audited net profit.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment